Yahoo Web Search

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 18 minutes ago

      Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery PR Newswire SAN

    • Q2 2024 Twist Bioscience Corp Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 hours ago

      The benefit of our business model is that we have diversified our revenue across many and applications with no single customer accounting for more than 10% of our revenue. In addition, we continue ...